Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 366.00
-8.00 (-2.14%)
Jan 9, 2026, 2:17 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 30.28 billion as of January 9, 2026. Its market cap has increased by 174.07% in one year.
Market Cap
30.28B
Enterprise Value
27.59B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
366.00
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 30.28B, an increase of 938.28%. That is a compound annual growth rate of 38.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 30.94B | -5.79% |
| Dec 31, 2025 | 32.84B | 203.76% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 220.10B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 75.48B |
| Bora Pharmaceuticals Co., LTD. | 67.22B |
| Heron Neutron Medical | 61.19B |
| Lumosa Therapeutics | 30.83B |
| Oneness Biotech | 30.14B |
| Center Laboratories | 30.05B |